← Leaderboards
Seongseok Yun
H. Lee Moffitt Cancer Ctr & Res Inst
$2,233,961
Attributed
$2,233,961
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $553K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,233,961 · 2
By mechanism
K08$1,127,879 · 1
R01$1,106,082 · 1
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Nicole Vincelette$157,248
Others in their field
Other Emerging Leaders on “Pathogenesis”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Thomas Denny · Duke University$22,999,550
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$17,335,818
Research focus
PathogenesisTranscription FactorIn VivoOncogenicPreclinical StudySignal TransductionDatabasesInsightMolecularNovel Therapeutic InterventionDrug ResistancePathway InteractionsProgramsSeer ProgramAcute Myelocytic LeukemiaClonal ExpansionHematologic NeoplasmsImpairmentAutomobile DrivingMaintenanceMolecular AbnormalityMolecular TargetCellsBiological
Grant awards (7)
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis$553,041
R01 · FY2025 · CA · contact PI
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis$553,041
R01 · FY2024 · CA · contact PI
Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia$172,871
K08 · FY2023 · CA · contact PI
Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia$238,752
K08 · FY2022 · CA · contact PI
Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia$238,752
K08 · FY2021 · CA · contact PI
Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia$238,752
K08 · FY2020 · CA · contact PI
Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia$238,752
K08 · FY2019 · CA · contact PI